High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

S Chow, V Galvis, M Pillai, R Leach, E Keene , A Spencer-Shaw, A Shablak, J Shanks , T Liptrot , F Thistlethwaite , Robert Hawkins

Research output: Contribution to journalArticlepeer-review

Search results